Quality of life of elderly patients submitted to antineoplastic chemotherapy treated at an oncology reference hospital/Qualidade de vida de idosos submetidos à quimioterapia antineoplásica atendidos em um hospital de referência oncológica

Souza, Jessika Cardoso de; Santos, Emerson Glauber Abreu dos; Santos, Anderson Lineu Siqueira dos; Santos, Maria Izabel Penha de Oliveira; Fernandes, Daiane de Souza; Oliveira, Tatyellen Natasha da Costa.
Rev Pan-Amaz Saude ; 9(3): 45-54, 2019. tab
Artigo em Português | Instituto Evandro Chagas (SOPHIA) | ID: iec-17565

Documentos relacionados

  1. Chemotherapy Induces Cancer-Fighting B Cells.
  2. Determinants of cancer drug pricing and how to overcome the cancer premium.
  3. Microbes mediated immunogenic cell death in cancer immunotherapy.
  4. Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors.
  5. Challenges and opportunities in oncology drug development and clinical research in China.
  6. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
  7. Connecting communities to tackle cancer from many sides.
  8. Type I interferon and cancer.
  9. DualGCN: a dual graph convolutional network model to predict cancer drug response.
  10. Large inherent variability in data derived from highly standardised cell culture experiments.